Proposed Data Collection Submitted for Public Comment and Recommendations, 56997-56999 [2015-23568]
Download as PDF
<![CDATA[
Federal Register / Vol. 80, No. 182 / Monday, September 21, 2015 / Notices
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2015–23567 Filed 9–18–15; 8:45 am]
BILLING CODE 4163–18–P
Docket Office, 1150 Tusculum Avenue,
Room 155, Cincinnati, OH 45226–1998.
FOR FURTHER INFORMATION CONTACT:
David L. Caruso, NIOSH, Office of the
Director, 626 Cochrans Mill Road,
Pittsburgh, PA 15236, (412) 386–6473
(not a toll-free number), Email: ake3@
cdc.gov.
SUPPLEMENTARY INFORMATION:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Background
Centers for Disease Control and
Prevention
[Docket Number CDC–2015–0080, NIOSH–
283]
NIOSH Oil and Gas Sector Program—
Strategic Plan for Research and
Prevention, 2016–2025; Request for
Comment
National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
ACTION: Notice of draft document
available for public comment.
AGENCY:
The National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC)
announces the availability of a draft
strategic plan entitled NIOSH Oil and
Gas Sector Program—Strategic Plan for
Research and Prevention, 2016–2025 for
public comment. The document and
instructions for submitting comments
can be found at www.regulations.gov.
DATES: Electronic or written comments
must be received by October 21, 2015.
ADDRESSES: You may submit comments,
identified by CDC–2015–0080 and
Docket Number NIOSH–283, by either
of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: National Institute for
Occupational Safety and Health, NIOSH
Docket Office, 1090 Tusculum Avenue,
MS C–34, Cincinnati, Ohio 45226–1998.
Instructions: All information received
in response to this notice must include
the agency name and docket number
[CDC–2015–0080; NIOSH–283]. All
relevant comments received will be
posted without change to
www.regulations.gov, including any
personal information provided. Please
make reference to CDC–2015–080 and
Docket Number NIOSH–283. All
information received in response to this
notice will also be available for public
examination and copying at the NIOSH
rmajette on DSK7SPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
15:14 Sep 18, 2015
Jkt 235001
The purpose of this strategic plan is
to define and prioritize occupational
safety and health research and
prevention activities for NIOSH in the
oil and gas exploration and production
industry through 2025. This strategic
plan focuses on conducting priority
research to prevent injuries, illnesses
and fatalities to workers employed in
the onshore, exploration and production
industry. The plan’s research goals are
organized according to the four areas
that make up the NIOSH Oil and Gas
Sector Program: (1) Epidemiology and
surveillance, (2) exposure assessment,
(3) control technologies, and (4)
communications. The plan also includes
performance measures that describe
specific research activities that will be
used to guide research, measure
progress, and evaluate the success of the
NIOSH Oil and Gas Sector Program in
improving safety and health in this
high-risk industry.
Information Needs
NIOSH is seeking public review and
comment on this document from
everyone with an interest in the health
and safety of workers in the oil and gas
extraction and production industry.
Dated: September 10, 2015.
John Howard,
Director, National Institute for Occupational
Safety and Health, Centers for Disease Control
and Prevention.
[FR Doc. 2015–23705 Filed 9–18–15; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–15–0009; Docket No. CDC–2015–
0083]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
56997
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing efforts to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed revision of the
information collection entitled
‘‘National Disease Surveillance
Program—I—Case Reports.’’
DATES: Written comments must be
received on or before November 20,
2015.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2015–
0083 by any of the following methods:
• Federal eRulemaking Portal:
Regulation.gov. Follow the instructions
for submitting comments.
• Mail: Leroy A. Richardson,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE., MS–
D74, Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to Regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
Regulations.gov.
Please note: All public comment
should be submitted through the
Federal eRulemaking portal
(Regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact the Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE., MS–D74, Atlanta,
Georgia 30329; phone: 404–639–7570;
Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
SUMMARY:
E:\FR\FM\21SEN1.SGM
21SEN1
56998
Federal Register / Vol. 80, No. 182 / Monday, September 21, 2015 / Notices
collection before submitting the
collection to OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
information.
Proposed Project
National Disease Surveillance
Program I—Case Reports—(OMB
Control Number 0920–0009, Expiration,
4/30/2016)—Revision—National Center
for Emerging and Zoonotic Infectious
Disease (NCEZID), Centers for Disease
Control and Prevention (CDC).
CDC currently collects data for certain
diseases in summary form under OMB
No. 0920–0004, (National Disease
Surveillance Program II—Disease
Summaries). These disease summaries
are for important, yet different types of
infections from those covered in this
disease case reports request.
Maintaining separate OMB numbers for
these two types of data collections
assists CDC in managing the two
surveillance activities.
CDC works with state health
departments to propose, coordinate, and
evaluate nationwide surveillance
systems. State epidemiologists are
responsible for the collection,
interpretation, and transmission of
medical and epidemiological
information to CDC.
The original purpose for reporting
communicable diseases was to
determine the prevalence of diseases
dangerous to public health. However,
collecting data also provided the basis
for planning and evaluating effective
programs for prevention and control of
infectious diseases. Current information
on disease incidence is needed to study
present and emerging disease problems.
CDC coordination of nationwide
reporting maintains uniformity so that
comparisons can be made from state to
state and year to year.
In addition to development of
prevention and control programs,
surveillance data serves as statistical
material for those engaged in research or
medical practice, aid to health
education officials and students, and
data for manufacturers of
pharmaceutical products. Annual
surveillance data are published in the
MMWR Surveillance Summary. The
total burden requested is 190 hours, a
decrease in 11,257 hours since the last
submission. This is due to the other
diseases moving to the Notifiable
Diseases Surveillance System (0920–
0728). There is no cost to respondents
other than their time.
Background and Brief Description
Surveillance of the incidence and
distribution of disease has been an
important function of the US Public
Health Service (PHS) since an 1878 Act
of Congress authorized the PHS to
collect morbidity reports. After the
Malaria Control in War Areas Program
had fulfilled its original 1942 objective
of reducing malaria transmission, its
basic tenets were carried forward and
broadened by the formation of the
Communicable Disease Center (CDC) in
1946. CDC was conceived of as a wellequipped, broadly staffed agency used
to translate facts about analysis of
morbidity and mortality statistics on
communicable diseases and through
field investigations.
The surveillance emphasis has shifted
as certain diseases have declined in
incidence, national emergencies have
prompted involvement in new areas,
and other diseases have taken on new
aspects. Surveillance for the following
diseases was approved three years ago:
Creutzfeldt-Jakob Disease (CJD),
Cyclosporiasis cayetanensis, Q Fever,
Dengue, Reye Syndrome, Hantavirus
pulmonary syndrome (HPS), Tick-borne
Rickettsial Disease, Kawasaki syndrome,
Trichinosis, Legionellosis, Tularemia,
Lyme Disease (LD), Typhoid Fever,
Malaria, Viral Hepatitis, and Plague.
Due to change requests and surveillance
systems moving to 0920–0728 (National
Notifiable Diseases Surveillance System
(NNDSS)) during the last three years,
the following diseases/conditions are
now included in this program:
Creutzfeldt-Jakob Disease (CJD), Reye
Syndrome, Kawasaki syndrome, and
Acute Flaccid Myelitis. CDC needs to
continue this surveillance package for
another 3 years to maintain continuity
in these surveillance systems. The data
throughout the years are used to
monitor the occurrence of non-notifiable
conditions and to plan and conduct
prevention and control programs at the
state, territorial, local and national
levels.
ESTIMATED ANNUALIZED BURDEN HOURS
rmajette on DSK7SPTVN1PROD with NOTICES
Type of respondents
Form name
Number of
respondents
Number of
responses per
respondent
Avg. burden
per response
(in hrs.)
Epidemiologist ...................................
Epidemiologist ...................................
Epidemiologist ...................................
Epidemiologist ...................................
Total ...........................................
CJD ..................................................
Kawasaki Syndrome ........................
Reye Syndrome ...............................
Acute Flaccid Myelitis ......................
..........................................................
20
55
50
100
........................
2
8
1
1
........................
20/60
15/60
20/60
30/60
........................
VerDate Sep<11>2014
15:14 Sep 18, 2015
Jkt 235001
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
E:\FR\FM\21SEN1.SGM
21SEN1
Total burden
(in hrs.)
13
110
17
50
190
Federal Register / Vol. 80, No. 182 / Monday, September 21, 2015 / Notices
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2015–23568 Filed 9–18–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers: CMS–1771]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services.
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995 (the
PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
any of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
SUMMARY:
Comments must be received by
November 20, 2015.
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
rmajette on DSK7SPTVN1PROD with NOTICES
DATES:
VerDate Sep<11>2014
15:14 Sep 18, 2015
Jkt 235001
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number llll, Room C4–26–
05, 7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ Web site address at
https://www.cms.hhs.gov/
PaperworkReductionActof1995.
2. Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov.
3. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
Reports Clearance Office at (410) 786–
1326.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES).
CMS–1771 Emergency and Foreign
Hospital Services
Under the PRA (44 U.S.C. 3501–
3520), federal agencies must obtain
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
The term ‘‘collection of information’’ is
defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA
requires federal agencies to publish a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, before
submitting the collection to OMB for
approval. To comply with this
requirement, CMS is publishing this
notice.
Title of Information Collection:
Emergency and Foreign Hospital
Services; Use: Section 1866 of the Social
Security Act states that any provider of
services shall be qualified to participate
in the Medicare program and shall be
eligible for payments under Medicare if
it files an agreement with the Secretary
to meet the conditions outlined in this
section of the Act. Section 1814(d)(1) of
the Social Security Act and 42 CFR
424.100, allows payment of Medicare
benefits for a Medicare beneficiary to a
nonparticipating hospital that does not
have an agreement in effect with the
Centers for Medicare and Medicaid
Services. These payments can be made
if such services were emergency
services and if CMS would be required
to make the payment if the hospital had
an agreement in effect and met the
conditions of payment. This form is
used in connection with claims for
emergency hospital services provided
by hospitals that do not have an
agreement in effect under Section 1866
of the Social Security Act. As specified
in 42 CFR 424.103(b), before a nonparticipating hospital may be paid for
emergency services rendered to a
Medicare beneficiary, a statement must
be submitted that is sufficiently
comprehensive to support that an
emergency existed. Form CMS–1771
contains a series of questions relating to
the medical necessity of the emergency.
The attending physician must attest that
the hospitalization was required under
the regulatory emergency definition and
give clinical documentation to support
the claim. A photocopy of the
beneficiary’s hospital records may be
used in lieu of the CMS–1771 if the
records contain all the information
required by the form. Form Number:
CMS–1771 (OMB control number:
0938–0023); Frequency: Annually;
Affected Public: Private sector (Business
or other for-profits and Not-for-profit
institutions); Number of Respondents:
100; Total Annual Responses: 200; Total
Annual Hours: 50. (For policy questions
regarding this collection contact
Shauntari Cheely at 410–786–1818.)
Dated: September 15, 2015.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
[FR Doc. 2015–23528 Filed 9–18–15; 8:45 am]
BILLING CODE 4120–01–P
Information Collection
1. Type of Information Collection
Request: Reinstatement without change
of a previously approved collection;
PO 00000
Frm 00040
Fmt 4703
Sfmt 9990
56999
E:\FR\FM\21SEN1.SGM
21SEN1
]]>Agencies
[Federal Register Volume 80, Number 182 (Monday, September 21, 2015)]
[Notices]
[Pages 56997-56999]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-23568]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-15-0009; Docket No. CDC-2015-0083]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing efforts to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies to take this opportunity to comment on proposed and/or
continuing information collections, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
revision of the information collection entitled ``National Disease
Surveillance Program--I--Case Reports.''
DATES: Written comments must be received on or before November 20,
2015.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2015-
0083 by any of the following methods:
Federal eRulemaking Portal: Regulation.gov. Follow the
instructions for submitting comments.
Mail: Leroy A. Richardson, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE., MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. All relevant comments received will be posted
without change to Regulations.gov, including any personal information
provided. For access to the docket to read background documents or
comments received, go to Regulations.gov.
Please note: All public comment should be submitted through the
Federal eRulemaking portal (Regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact the Information Collection Review Office,
Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS-
D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
[[Page 56998]]
collection before submitting the collection to OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; (d) ways to
minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology; and (e) estimates of capital or start-
up costs and costs of operation, maintenance, and purchase of services
to provide information. Burden means the total time, effort, or
financial resources expended by persons to generate, maintain, retain,
disclose or provide information to or for a Federal agency. This
includes the time needed to review instructions; to develop, acquire,
install and utilize technology and systems for the purpose of
collecting, validating and verifying information, processing and
maintaining information, and disclosing and providing information; to
train personnel and to be able to respond to a collection of
information, to search data sources, to complete and review the
collection of information; and to transmit or otherwise disclose the
information.
Proposed Project
National Disease Surveillance Program I--Case Reports--(OMB Control
Number 0920-0009, Expiration, 4/30/2016)--Revision--National Center for
Emerging and Zoonotic Infectious Disease (NCEZID), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
Surveillance of the incidence and distribution of disease has been
an important function of the US Public Health Service (PHS) since an
1878 Act of Congress authorized the PHS to collect morbidity reports.
After the Malaria Control in War Areas Program had fulfilled its
original 1942 objective of reducing malaria transmission, its basic
tenets were carried forward and broadened by the formation of the
Communicable Disease Center (CDC) in 1946. CDC was conceived of as a
well-equipped, broadly staffed agency used to translate facts about
analysis of morbidity and mortality statistics on communicable diseases
and through field investigations.
The surveillance emphasis has shifted as certain diseases have
declined in incidence, national emergencies have prompted involvement
in new areas, and other diseases have taken on new aspects.
Surveillance for the following diseases was approved three years ago:
Creutzfeldt-Jakob Disease (CJD), Cyclosporiasis cayetanensis, Q Fever,
Dengue, Reye Syndrome, Hantavirus pulmonary syndrome (HPS), Tick-borne
Rickettsial Disease, Kawasaki syndrome, Trichinosis, Legionellosis,
Tularemia, Lyme Disease (LD), Typhoid Fever, Malaria, Viral Hepatitis,
and Plague. Due to change requests and surveillance systems moving to
0920-0728 (National Notifiable Diseases Surveillance System (NNDSS))
during the last three years, the following diseases/conditions are now
included in this program: Creutzfeldt-Jakob Disease (CJD), Reye
Syndrome, Kawasaki syndrome, and Acute Flaccid Myelitis. CDC needs to
continue this surveillance package for another 3 years to maintain
continuity in these surveillance systems. The data throughout the years
are used to monitor the occurrence of non-notifiable conditions and to
plan and conduct prevention and control programs at the state,
territorial, local and national levels.
CDC currently collects data for certain diseases in summary form
under OMB No. 0920-0004, (National Disease Surveillance Program II--
Disease Summaries). These disease summaries are for important, yet
different types of infections from those covered in this disease case
reports request. Maintaining separate OMB numbers for these two types
of data collections assists CDC in managing the two surveillance
activities.
CDC works with state health departments to propose, coordinate, and
evaluate nationwide surveillance systems. State epidemiologists are
responsible for the collection, interpretation, and transmission of
medical and epidemiological information to CDC.
The original purpose for reporting communicable diseases was to
determine the prevalence of diseases dangerous to public health.
However, collecting data also provided the basis for planning and
evaluating effective programs for prevention and control of infectious
diseases. Current information on disease incidence is needed to study
present and emerging disease problems. CDC coordination of nationwide
reporting maintains uniformity so that comparisons can be made from
state to state and year to year.
In addition to development of prevention and control programs,
surveillance data serves as statistical material for those engaged in
research or medical practice, aid to health education officials and
students, and data for manufacturers of pharmaceutical products. Annual
surveillance data are published in the MMWR Surveillance Summary. The
total burden requested is 190 hours, a decrease in 11,257 hours since
the last submission. This is due to the other diseases moving to the
Notifiable Diseases Surveillance System (0920-0728). There is no cost
to respondents other than their time.
Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of Avg. burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hrs.) (in hrs.)
--------------------------------------------------------------------------------------------------------------------------------------------------------
Epidemiologist................................. CJD.................................... 20 2 20/60 13
Epidemiologist................................. Kawasaki Syndrome...................... 55 8 15/60 110
Epidemiologist................................. Reye Syndrome.......................... 50 1 20/60 17
Epidemiologist................................. Acute Flaccid Myelitis................. 100 1 30/60 50
Total...................................... ....................................... .............. .............. .............. 190
--------------------------------------------------------------------------------------------------------------------------------------------------------
[[Page 56999]]
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2015-23568 Filed 9-18-15; 8:45 am]
BILLING CODE 4163-18-P
